Abingworth Archives

News and Trends 10 Dec 2021

European Biotech Investors Cap Off Record Year in Fundraising

The year 2021 is closing with a biotech investment rush as Eir Ventures, Apollo Health Ventures, and Merck’s venture capital arm M Ventures raise impressive funds to speed up life sciences innovation. This year is set to break records in terms of the money flowing into institutional life science investors. With 2021 not even finished, […]

December 10, 2021 - 4 minutesmins - By Jonathan Smith

uk vc firm investment biotech life sciences

News and Trends 16 Jul 2021

Multi-Million UK Life Sciences Initiative Welcomed By VC Firms

Biotech venture capital firms across Europe have warmly received the launch of a €235M (£200M) UK government initiative to support the growth of promising late-stage life sciences companies. The UK’s Life Sciences Investment Programme opened to applications from fund managers this month, with the aim of providing €235M in late-stage capital and attracting at least […]

July 16, 2021 - 4 minutesmins - By Anita Chakraverty

Interview 16 Jan 2019

The Coming of Age of Biotechnology

Since its beginnings in the 1970s, the biotech industry has grown massively and made huge advances. At our recent Labiotech Refresh in London, Tim Haines, Managing Partner at the life science VC Abingworth, shared his views on how biotechnology has finally come of age. Haines knows the biotech industry well. After leading and helping sell […]

January 16, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 Jul 2018

Abingworth Closes €268M to Invest in Life Science Companies

Abingworth has closed $315M (€268M) for its most recent fund, Abingworth Bioventures VII, which invests in European and US life science companies. In the current fundraising, Abingworth surpassed its target of $300M. The new fund will invest in life science companies in all stages of development, including early and late-stage venture deals. The company plans to […]

July 9, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 19 Sep 2016

Abingworth launches UK Immuno-Oncology Startup with Seed Funding

Just when we thought it couldn’t become any more intense, the field of immuno-oncology is heating up. VC giant Abingworth has seeded a new UK startup, GammaDelta Therapeutics, to bring its T cell therapy to the clinic. Abingworth, a huge British VC firm, has thrown its weight behind a new London-based immuno-oncology startup, GammaDelta Therapeutics. […]

September 19, 2016 - 3 minutesmins - By Evelyn Warner

Europe VC top investors biotech life sciences finance

Best in Biotech 12 Apr 2016

18 of the Best European VCs for Biotech in 2016

As Genentech is celebrating its 40th Birthday, it is also the 40th birthday of Biotechnology and the 40th birthday of Biotech Venture Capitalists. These risk investors are deeply linked to any venture successes. And although Europe definitely has fewer than in the US, there’s still a significant amount of influence and wealth on this side […]

April 12, 2016 - 10 minutesmins - By Philip Hemme

medicxi venture index fund uk genmab jjdc gsk fund

News and Trends 2 Feb 2016

New €210M Life Sciences Fund is Launched in UK

Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches as an Independent Venture Capital Firm and Announces Closing of a €210M Fund including GSK and Johnson & Johnson Innovation. Medicxi Ventures is based in London, Geneva and Jersey and has been investing in the Life Sciences field for over 20 years. It comprises all of the legacy portfolio […]

February 2, 2016 - 2 minutesmins - By Dani Bancroft

kesios myeloma imperial innovations london

News and Trends 2 Dec 2015

An Imperial College Based Start-Up Has Raised €27M in Series A for a Blood Cancer Drug

Kesios is a start-up Biotech based in London (UK) which has raised over €27M in a Series A funding round for its pipeline targeting the fight against multiple myeloma. A syndicate of UK investors has jumped at the chance to fund this cancer-fighting biotech, whose nuclear factor kappa B (NF-κB)signal pathway targeting pipeline has promise […]

December 2, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 13 Oct 2015

The Top 15 European Biotech VCs

Biotech wouldn’t exist without Venture Capitalists. These investors bring the cash necessary to run clinical trials or conduct the scaling-up of processes, along with many years of experience. Though admittedly Europe definitely hasn’t got as much money floating around as the US, there are many major Biotech VCs in Europe … Here are 15 of […]

October 13, 2015 - 9 minutesmins - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Abingworth

European Biotech Investors Cap Off Record Year in Fundraising

Multi-Million UK Life Sciences Initiative Welcomed By VC Firms

The Coming of Age of Biotechnology

Abingworth Closes €268M to Invest in Life Science Companies

Abingworth launches UK Immuno-Oncology Startup with Seed Funding

18 of the Best European VCs for Biotech in 2016

New €210M Life Sciences Fund is Launched in UK

An Imperial College Based Start-Up Has Raised €27M in Series A for a Blood Cancer Drug

The Top 15 European Biotech VCs

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!